News Shortcuts from other journals

Fenofibrate may reduce the risk of diabetic retinopathy

BMJ 2007; 335 doi: (Published 15 November 2007) Cite this as: BMJ 2007;335:1017

The lipid lowering agent fenofibrate could be useful for treating diabetic retinopathy if findings from a recent clinical trial are confirmed. Nearly 10 000 patients with type 2 diabetes took fenofibrate or a placebo for five years in addition to their usual …

View Full Text

Sign in

Log in through your institution